Treace Medical Concepts, Inc. (TMCI)
Market Cap | 460.18M |
Revenue (ttm) | 209.36M |
Net Income (ttm) | -55.74M |
Shares Out | 62.87M |
EPS (ttm) | -0.90 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 332,540 |
Open | 7.40 |
Previous Close | 7.26 |
Day's Range | 6.94 - 7.40 |
52-Week Range | 3.92 - 11.33 |
Beta | 0.80 |
Analysts | Hold |
Price Target | 8.79 (+20.08%) |
Earnings Date | May 8, 2025 |
About TMCI
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adduc... [Read more]
Financial Performance
In 2024, Treace Medical Concepts's revenue was $209.36 million, an increase of 11.89% compared to the previous year's $187.12 million. Losses were -$55.74 million, 12.6% more than in 2023.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for TMCI stock is "Hold." The 12-month stock price forecast is $8.79, which is an increase of 20.08% from the latest price.
News

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Treace Medical To Contact Him Directly To Discuss Their Options If you purchased or a...

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 10, 2025 in Treace Medical Concepts, Inc. Lawsuit – TMCI
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI).

Treace to Report First Quarter 2025 Financial Results on May 8, 2025
PONTE VEDRA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgic...

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical
NEW YORK CITY, NY / ACCESS Newswire / April 19, 2025 / Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace Medic...

Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference
PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgic...

Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference
Expands market-leading position with new best-in-class bunion technologies Expands market-leading position with new best-in-class bunion technologies

The Schall Law Firm Invites Investors With Losses In Treace Medical Concepts, Inc. To Join A Securities Fraud Investigation
LOS ANGELES, CA / ACCESS Newswire / March 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medic...

Treace Medical Concepts, Inc. (TMCI) Q4 2024 Earnings Call Transcript
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants Vivian Cervantes - Investor Relations, Gilmartin Group John Treace - Chi...

Treace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025
PONTE VEDRA, Fla., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgica...

The Schall Law Firm Invites Investors With Losses To Join An Investigation Into Treace Medical Concepts, Inc. For Securities Fraud
LOS ANGELES, CA / ACCESS Newswire / February 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Me...

Treace Medical Concepts, Inc. Is Being Investigated For Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / January 30, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Me...

Treace Medical Concepts, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / January 23, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Me...

Treace Medical Concepts, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / January 19, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Me...

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
LOS ANGELES, CA / ACCESS Newswire / January 18, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Me...

The Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors.